In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Eurogene and Valentis initiate trial for prevention of blood vessel hyperplasia
Valentis enters cross license agreement with Genzyme
Valentis Expands License Agreement With Genzyme Corporation
Valentis introduces new gene delivery systems for secreted proteins
Valentis licenses GeneSwitch to Medigene
Juvaris BioTherpeutics Expands Relationship With Valentis
Third US patent for Valentis GeneSwitch
Valentis and Boehringer Ingelheim to collaborate on rheumatoid arthritis therapy